Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (18)

1

The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment

enthalten in: Blood advances | 2023

von Eickhardt-Dalbøge, C. | Ingham, A. | Andersen, L. | +13

2

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

enthalten in: Blood advances | 2022

von Knudsen, T. | Skov, V. | Stevenson, K. | +29

3

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms : minimal residual disease and cure?

enthalten in: Seminars in immunopathology | 2019

von Hasselbalch, H. | Holmström, M.

4

The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms

enthalten in: Leukemia & lymphoma | 2017

von Skov, V. | Riley, C. | Thomassen, M. | +5

5

Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs : The proof of concept in early myelofibrosis

enthalten in: Cancer | 2017

von Hasselbalch, H.

CommentOn: Cancer. 2017 Jul 15;123(14):2680-2687. - PMID 28518222

6

Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib

enthalten in: Expert review of hematology | 2017

von Bjørn, M. | Hasselbalch, H.

7

Second malignancies in hydroxyurea and interferon-treated Philadelphia-negative myeloproliferative neoplasms

enthalten in: European journal of haematology | 2017

von Hansen, I. | Sørensen, A. | Hasselbalch, H.

8

Optimal therapy for polycythemia vera and essential thrombocythemia : Preferred use of interferon therapy based on phase 2 trials

enthalten in: Hematology (Amsterdam, Netherlands) | 2016

von Silver, R. | Hasselbalch, H.

9

Status and perspectives on chronic myeloproliferative neoplasm treatment

enthalten in: Ugeskrift for laeger | 2015

von Ocias, L. | Holmström, M. | Riley, C. | +10

10

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha

enthalten in: Leukemia research | 2013

von Stauffer Larsen, T. | Iversen, K. | Hansen, E. | +12